01.15.2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
On Thursday (14/1), were suspended several batches of medicines company Prati Donaduzzi & Cia Ltda manufactured in violation of the registration at Anvisa.
The decision came because the company changed the production process of the items listed below, without prior evaluation of the Agency, and therefore the distribution, sale and use of products should be discontinued. The existing stock on the market should also be collected.
Check out lots of banned drugs
Product Lot
DICLOFENAC SODIUM 50mg tablet Lots produced up to 10/19/2015 at odds with the record.
Erythromycin estolate 50 mg / mL oral suspension All valid batches produced at odds with the record.
NIMESULIDE 50mg / ml oral suspension All valid batches produced at odds with the record
The measure is in Resolution 88/2016 published in the Official Gazette (DOU).
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.